Código QR

Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder

Jose Martinez-Raga,1,2 Carlos Knecht,3 Raquel de Alvaro4 1Teaching Unit of Psychiatry and Psychological Medicine, University Hospital Doctor Peset, University of Valencia, 2CEU Cardenal Herrera University, 3Área de Salud Mental, Hospital Padre Jofré, Valencia, 4Hospital Genera...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Martinez-Raga J, Knecht C, de Alvaro R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/ba41f52a828c40d0ba9b110788e4a058
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
por: Huss M, et al.
Publicado: (2016)

Treatment of adults with attention-deficit/hyperactivity disorder
por: Dusan Kolar, et al.
Publicado: (2008)

Treatment of adults with attention-deficit/hyperactivity disorder
por: Dusan Kolar, et al.
Publicado: (2008)

Attention-deficit/hyperactivity disorder in postsecondary students
por: Nugent K, et al.
Publicado: (2014)

Attention-deficit-hyperactivity disorder and reward deficiency syndrome
por: Kenneth Blum, et al.
Publicado: (2008)

Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
por: Jan K Buitelaar, et al.
Publicado: (2009)

Electroencephalography signatures of attention-deficit/hyperactivity disorder: clinical utility
por: Alba G, et al.
Publicado: (2015)

Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
por: Rajasree Nair, et al.
Publicado: (2009)

Sleep and cognitive problems in patients with attention-deficit hyperactivity disorder
por: Lee HK, et al.
Publicado: (2014)

Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder
por: Lamberti M, et al.
Publicado: (2015)

Prevalence and correlates of attention-deficit hyperactivity disorder symptoms in Korean college students
por: Kwak YS, et al.
Publicado: (2015)

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
por: Paul Hammerness, et al.
Publicado: (2009)

Psychopathology, symptoms of attention-deficit/hyperactivity disorder, and risk factors in juvenile offenders
por: Margari F, et al.
Publicado: (2015)

Attention-deficit hyperactivity disorder and impulsivity in female patients with fibromyalgia
por: Yilmaz E, et al.
Publicado: (2018)

Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom study
por: L&oacute;pez F, et al.
Publicado: (2011)

Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD)
por: Evangelia Stergiakouli, et al.
Publicado: (2010)

Distinguishing between attention-deficit hyperactivity and fetal alcohol spectrum disorders in children: clinical guidelines
por: Elizabeth Peadon, et al.
Publicado: (2010)

Neurofibromatosis type 1 and attention deficit hyperactivity disorder: a case study and literature review
por: Miguel CS, et al.
Publicado: (2015)

Persisting primitive reflexes in medication-naïve girls with attention-deficit and hyperactivity disorder
por: Konicarova J, et al.
Publicado: (2013)

Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study
por: Valdiz&aacute;n-Us&oacute;n JR, et al.
Publicado: (2013)

Adult attention-deficit hyperactivity disorder, risky behaviors, and motorcycle injuries: a case-control study
por: Sadeghi-Bazargani H, et al.
Publicado: (2015)

Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges
por: Williams AE, et al.
Publicado: (2016)

Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review
por: Gajria K, et al.
Publicado: (2014)

Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation
por: Marty Hinz, et al.
Publicado: (2011)

Effects of psycho-educational training and stimulant medication on visual perceptual skills in children with attention deficit hyperactivity disorder
por: Antigone S Papavasiliou, et al.
Publicado: (2007)

A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder
por: Maneeton N, et al.
Publicado: (2014)

Psychiatric comorbidity distribution and diversities in children and adolescents with attention deficit/hyperactivity disorder: a study from Turkey
por: Y&uuml;ce M, et al.
Publicado: (2013)

The Effect of Viloxazine Extended-Release Capsules on Functional Impairments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents in Four Phase 3 Placebo-Controlled Trials
por: Nasser A, et al.
Publicado: (2021)

Social function of adult men with attention-deficit/hyperactivity disorder in the context of military service
por: Noh GM, et al.
Publicado: (2018)

Once-daily treatment of ADHD with guanfacine: patient implications
por: Brandon C Strange
Publicado: (2008)

Attention deficit hyperactivity disorder and disordered eating behaviors: links, risks, and challenges faced
por: Ptacek R, et al.
Publicado: (2016)

Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatment
por: Königs A, et al.
Publicado: (2016)

Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies
por: Wigal SB, et al.
Publicado: (2020)

Sleep problems in children with autism spectrum disorder: clinical correlates and the impact of attention deficit hyperactivity disorder
por: Gunes S, et al.
Publicado: (2019)

Comparison of Persistence and Adherence Between Adults Diagnosed with Attention Deficit/Hyperactivity Disorder in Childhood and Adulthood
por: Lee SM, et al.
Publicado: (2021)

Potential role of pre- and postnatal testosterone levels in attention-deficit/hyperactivity disorder: is there a sex difference?
por: Wang LJ, et al.
Publicado: (2017)

Attention Deficit Hyperactivity Disorder And Borderline Personality Disorder In Adults: A Review Of Their Links And Risks
por: Weiner L, et al.
Publicado: (2019)

A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder
por: Craig F, et al.
Publicado: (2016)

The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies
por: Aagaard L, et al.
Publicado: (2011)

A preliminary report of the dopamine receptor D4 and the dopamine transporter 1 gene polymorphism and its association with attention deficit hyperactivity disorder
por: Helmut Niederhofer, et al.
Publicado: (2008)